Eli Lilly to amass Akouos for as much as about $610 million and develop gene therapies for listening…
Eli Lilly and Co.
LLY,
+0.41%
mentioned Tuesday it has entered an settlement to amass Akouos Inc.
AKUS,
-5.14%,
an organization growing a portfolio of viral gene therapies for…